Cargando…
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
Cytotoxic therapies, besides directly inducing cancer cell death, can stimulate immune-dependent tumor growth control or paradoxically accelerate tumor progression. The underlying mechanisms dictating these opposing outcomes are poorly defined. Here, we show that cytotoxic therapy acutely upregulate...
Autores principales: | Bell, Charlotte R., Pelly, Victoria S., Moeini, Agrin, Chiang, Shih-Chieh, Flanagan, Eimear, Bromley, Christian P., Clark, Christopher, Earnshaw, Charles H., Koufaki, Maria A., Bonavita, Eduardo, Zelenay, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018752/ https://www.ncbi.nlm.nih.gov/pubmed/35440553 http://dx.doi.org/10.1038/s41467-022-29606-9 |
Ejemplares similares
-
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
por: Bonavita, Eduardo, et al.
Publicado: (2020) -
Resolving the dark side of therapy-driven cancer cell death
por: Bonavita, Eduardo, et al.
Publicado: (2018) -
COX-2 upregulation by tumour cells post-chemotherapy fuels the immune evasive dark side of cancer inflammation
por: Bell, Charlotte R., et al.
Publicado: (2022) -
Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?
por: Edelmann, Jennifer, et al.
Publicado: (2023) -
Cell of origin in biliary tract cancers and clinical implications
por: Moeini, Agrin, et al.
Publicado: (2021)